OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
December 08, 2023
MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.
December 06, 2023
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
December 03, 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Collaboration is a key component to achieving long-term success with genetic medicines.
Digital transformation allows for smarter and connected biomanufacturing operations.
December 02, 2023
Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.
December 01, 2023
Novo Nordisk will invest more than DKK 16 billion (US$2.3 billion) to expand its production facilities in Chartres, France.
November 30, 2023
Exagamglogene autotemcel seen as synechdoche.
November 29, 2023
TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.
Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.